(Q33978627)

30 July 2017

title

Efficacy of a new cream formulation of mupirocin: comparison with oral and topical agents in experimental skin infections (English)

1 reference

30 July 2017

1 reference

J Gisby

1

1 reference

30 July 2017

J Bryant

series ordinal

2

1 reference

30 July 2017

language of work or name

English

0 references

publication date

1 February 2000

1 reference

Antimicrobial Agents and Chemotherapy

30 July 2017

published in

1 reference

30 July 2017

volume

44

1 reference

30 July 2017

issue

2

1 reference

30 July 2017

page(s)

255-260

1 reference

A double-blind, randomized, placebo-controlled clinical trial to evaluate the safety and efficacy of mupirocin calcium ointment for eliminating nasal carriage of Staphylococcus aureus among hospital personnel.

30 July 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89667

Flucloxacillin, a New Isoxazolyl Penicillin, Compared with Oxacillin, Cloxacillin, and Dicloxacillin

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89667

Experimental Infection of the Skin in the Hamster Simulating Human Impetigo. I. Natural History of the Infection

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89667

Antibacterial activity of mupirocin (pseudomonic acid), a new antibiotic for topical use.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89667

Response of Streptococcus pyogenes to therapy with amoxicillin or amoxicillin-clavulanic acid in a mouse model of mixed infection caused by Staphylococcus aureus and Streptococcus pyogenes

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89667

Randomized clinical trial of topical mupirocin versus oral erythromycin for impetigo

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89667

Impetigo: a reassessment of etiology and therapy.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89667

Determinants of non-compliance with short term antibiotic regimens

5 July 2018

2 references

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89667

5 July 2018

12 December 2020

Value of charcoal media for recovering staphylococci incorporated in mupirocin ointment

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89667

Efficacy and safety of 2% mupirocin ointment in the treatment of primary and secondary skin infections--an open multicentre trial

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89667

Topical 2% mupirocin versus 2% fusidic acid ointment in the treatment of primary and secondary skin infections

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89667

Clinical relevance of resistance to fusidic acid in Staphylococcus aureus

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89667

Comparison of mupirocin and erythromycin in the treatment of impetigo

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89667

A bacteriologically controlled, randomized study comparing the efficacy of 2% mupirocin ointment (Bactroban) with oral erythromycin in the treatment of patients with impetigo

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89667

Minimal dose requirements for nasal mupirocin and its role in the control of epidemic MRSA.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89667

Double-blind study comparing erythromycin and mupirocin for treatment of impetigo in children: implications of a high prevalence of erythromycin-resistant Staphylococcus aureus strains

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89667

Characterization and quantitation of experimental surgical-wound infections used to evaluate topical antibacterial agents

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89667

Comparative pharmacology of cefaclor and cephalexin

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89667

Antibiotic-resistant Staphylococcus aureus in dermatology and burn wards

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89667

On the mode of action of pseudomonic acid: inhibition of protein synthesis in Staphylococcus aureus

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89667

Evolution of antibiotic resistance in Staphylococcus aureus: the role of the skin

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89667

Efficacy of mupirocin calcium ointment in the treatment of experimental wound infections caused by methicillin-resistant strains of Staphylococcus aureus.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89667

Elimination of Staphylococcus aureus nasal carriage in health care workers: analysis of six clinical trials with calcium mupirocin ointment. The Mupirocin Collaborative Study Group.

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89667

A comparison of the new topical antibiotic mupirocin ('Bactroban') with oral antibiotics in the treatment of skin infections in general practice

29 October 2018

1 reference

12 December 2020

Mupirocin-resistant Staphylococcus aureus

1 reference

12 December 2020

Impetigo. Current etiology and comparison of penicillin, erythromycin, and cephalexin therapies

1 reference

12 December 2020

Pseudomonic acid: a new topical antimicrobial agent

1 reference

12 December 2020

A three-year study of impetigo in Sydney

1 reference

12 December 2020

A Hamster Model for Streptococcal Impetigo

1 reference

12 December 2020

Experimental infection of the skin in the hamster simulating human impetigo. II. Assessment of various therapeutic regimens

1 reference

12 December 2020

Pseudomonic Acid: an Antibiotic produced by Pseudomonas fluorescens

1 reference

12 December 2020

Fate of single oral doses of erythromycin acistrate, erythromycin stearate and pelleted erythromycin base analysed by mass-spectrometry in plasma of healthy human volunteers

1 reference

12 December 2020

A comparison of sodium fusidate ointment and mupirocin ointment in superficial skin sepsis

1 reference

12 December 2020

Topical mupirocin versus topical neosporin in the treatment of cutaneous infections

1 reference

12 December 2020

Topical antibiotics in the treatment of superficial skin infections in general practice--a comparison of mupirocin with sodium fusidate

1 reference

12 December 2020

10.1128/AAC.44.2.255-260.2000

Identifiers

DOI

1 reference

30 July 2017

1 reference

30 July 2017

1 reference